December 12, 2003
Speaker Biographies
John E. Calfee is a resident scholar at AEI. From 1980 to 1986, he served in the Bureau of Economics at the Federal Trade Commission. Mr. Calfee taught marketing and consumer behavior in the business schools of the University of Maryland at College Park and Boston University, and he was a visiting senior fellow at the Brookings Institution. He is the author of Prices, Markets, and the Pharmaceutical Revolution (AEI Press, 2000) and Fear of Persuasion: A New Perspective on Advertising and Regulation (distributed by AEI Press, 1997).
Patricia M. Danzon is the Celia Moh Professor of health care systems and insurance and risk management at the Wharton School of the University of Pennsylvania and is an adjunct scholar at AEI. She was a visiting professor of business economics at the University of Chicago, an associate professor at Duke University, a senior research fellow at the Hoover Institution at Stanford University, and a research economist at the RAND Corporation. Ms. Danzon’s major research interests include the international pharmaceutical industry, health care economics and policy, managed care, and medical liability systems. She is associate editor of the Journal of Health Economics. She is the author of Price Comparisons for Pharmaceuticals: A Review of U.S. and Cross-National Studies (AEI Press, 1999), Pharmaceutical Price Regulation (AEI Press, 1997), Global Budgets versus Competitive Cost-Control Strategies (AEI Press, 1994), Responsible National Health Insurance with Mark Pauly, Paul Feldstein, and John Hoff (AEI Press, 1992), and Medical Malpractice: Theory, Evidence and Public Policy (Harvard University Press, 1985).
Robert B. Helms is a resident scholar and the director of health policy studies at AEI. He has written and lectured extensively on health policy, health economics, and pharmaceutical economic issues. Mr. Helms currently participates in the Consensus Group, an informal task force that is developing market-oriented health reform concepts. From 1981 to 1989, he served as the assistant secretary for planning and evaluation and deputy assistant secretary for health policy in the Department of Health and Human Services. Mr. Helms is the editor of several AEI publications on health policy: Medicare in the Twenty-first Century: Seeking Fair and Efficient Reform; American Health Policy: Critical Issues for Reform; Health Policy Reform: Competition and Controls; Health Care Policy and Politics: Lessons from Four Countries; and Competitive Strategies in the Pharmaceutical Industry.
Judith Wagner is a scholar in residence at the Institute of Medicine. She has more than thirty years experience in health policy analysis and health technology economics. Most recently, as a senior analyst at the Congressional Budget Office, Ms. Wagner analyzed prescription-drug issues, including the design of a Medicare prescription-drug benefit, Medicaid drug payment, and reform of current laws governing the entry of generic drugs into the market place. Before joining CBO, she was a consultant at the Mayo Clinic in Rochester, Minnesota, where she conducted cost and cost-effectiveness analyses of medical of medical procedures and technologies for both research and operational planning at the clinic. At the Office of Technology Assessment, Ms. Wagner managed many assessments, most notably a 1993 study of the economics of pharmaceutical R&D, which estimated the cost and profitability of private investment in the development of new drugs and examined the impact of public policies on the patterns of drug R&D in the private sector.
View Event Details
